Contact
searchSearch
HMP Global

Meeting Materials

S1
Network Meta-analysis to Evaluate the Comparative Efficacy of Advanced Therapies as First-Line Treatment for Maintenance Treatment of Adult Patients With Moderate to Severe Crohn's Disease
Background: Subcutaneous (SC) CT-P13 provides patients and physicians with a new opportunity for maintenance treatment of Crohn’s disease (CD). Given the rapidly expanding ther...
12/20/2024
S1
Impact of Obefazimod Induction Therapy on Histologic and Combined Histologic and Endoscopic Outcomes in Patients With Moderately to Severely Active Ulcerative Colitis: Week 8 Results from the Phase 2b Induction Trial
Background: Obefazimod is an investigational, oral, once-daily (od), small molecule which enhances expression of microRNA-124 and is currently in phase 3 clinical trials for the treatment...
12/20/2024
S1
Integrated Long-Term Safety of Ozanimod Across Two Different Indications: Results from Clinical Trials in Patients With Moderately to Severely Active Ulcerative Colitis or Relapsing Multiple Sclerosis
Background:
12/20/2024
S2
Sustained Improvements in Health-Related Quality of Life Outcomes With Long-Term Risankizumab Treatment in Patients With Moderately to Severely Active Crohn’s Disease: Results from the FORTIFY Open-Label, Long-Term Extension
Background:
12/20/2024
S2
The Sphingosine 1-Phosphate Receptor Modulator Amiselimod is Efficacious for the Treatment of Active Ulcerative Colitis: Results from a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial
Background: There remains an unmet medical need for active ulcerative colitis (UC) treatments. Amiselimod is an investigational oral, sphingosine 1-phosphate (S1P) receptor modulator (hig...
12/20/2024
S3
Cancer-Predisposing Germline Variants in Inflammatory Bowel Disease: A Three-Cohort Comparison of Patients With and Without Primary Sclerosing Cholangitis
Background: Primary sclerosing cholangitis (PSC) is a significant risk factor for developing colorectal cancer (CRC) in patients with inflammatory bowel disease (IBD). While there are kno...
12/20/2024
S2
Empowering Patients to Participate in Clinical Visits: A Patient-Guided Checklist for Young Adults Living With Inflammatory Bowel Disease
Background:
12/20/2024
S3
Efficacy and Safety of Obefazimod in Patients With Ulcerative Colitis at Week 48 of an Open-Label Maintenance Study Among Clinical Nonresponses at Week 8 of the Phase 2b Induction Trial
Background:
12/20/2024
S2
The Association of Endoscopic Outcomes With Improvement in Long-Term Clinical Outcomes in Patients With Moderate to Severe Crohn’s Disease Treated With Risankizumab: Results from the Phase 3 FORTIFY Open-Label Extension Trial
Background: Endoscopic healing is an important long-term treatment goal in Crohn’s disease (CD) per STRIDE II consensus recommendations. Here, the relationship between endoscop...
12/20/2024
S3
Mental Health Comorbidities and Outcomes in Transgender and Gender Nonconforming Patients With Inflammatory Bowel Disease
Background: Prior studies have demonstrated high rates of mental health comorbidities in transgender and gender nonconforming (TGNC) individuals as well as patients with inflammatory bowe...
12/20/2024
S4
Contemporary Surgical Management of Ileosigmoid Fistulas in Crohn’s Disease: A Systematic Review and Meta-analysis
Background: Ileosigmoid fistula (ISF) is a common complication of Crohn’s disease that is often diagnosed intraoperatively. Surgical management varies, including rates of lapar...
12/20/2024
S4
Anxiety and Depression are Key Factors Affecting Sleep Quality in Patients With Inflammatory Bowel Disease, Independent of Disease Activity
Background: Anxiety, depression, and poor sleep quality (PSQ) are more prevalent in patients with inflammatory bowel disease (IBD) than in the general population and associated with incre...
12/20/2024
S4
RO7790121 as Treatment for Moderately to Severely Active Ulcerative Colitis: Efficacy and Health-Related Quality of Life Improvements: Results from the Phase IIb TUSCANY-2 Trial
Background:
12/20/2024
S5
Inflammatory Bowel Disease Outcomes in Transgender and Gender Nonconforming Patients Receiving Gender-Affirming Hormone Therapy
Background: Little is known about IBD outcomes in transgender and gender nonconforming (TGNC) patients receiving gender-affirming hormone (GAH) therapy. The aim of this study was to compa...
12/20/2024
S4
Burden and Impact of Abdominal Pain in Moderate to Severe Crohn’s Disease and Ulcerative Colitis: Results from the Communicating Needs and Features of IBD Experiences (CONFIDE) Survey
Background: Abdominal pain (AP) is a common symptom of Crohn’s disease (CD) and ulcerative colitis (UC), affecting up to 70% of patients. The Communicating Needs and Features o...
12/20/2024
S6
Real-World Efficacy and Safety of Ozanimod in US Patients With Moderately to Severely Active Ulcerative Colitis: Initial Results from POLARIS, an Ongoing Phase 4 Open-Label Study
Background: Ozanimod (OZA) is an oral, selective sphingosine 1-phosphate receptor 1 and 5 modulator approved for the treatment of moderately to severely active ulcerative colitis (UC) in ...
12/20/2024
S5
Outcomes of Use of Advanced Therapies in the Management of Inflammatory Bowel Disease Post-liver Transplant
Background:
12/20/2024
S7
Transforming Endoscopic Documentation: Novel Artificial Intelligence Summarization Techniques for Pouchoscopy Videos
Background:
12/20/2024
S5
Patient and Provider Distributions Reveal Regional Disparities in Advanced Therapy Utilization for Ulcerative Colitis in the United States
Background:
12/20/2024
S8
Clinical Effectiveness and Safety of Vedolizumab Versus Infliximab in Biologic-Naïve Ulcerative Colitis Patients: A Real-World Multicentric Observational Study
Background: Vedolizumab (VDZ) and infliximab (IFX) are considered first-line agents in the treatment of moderate to severe ulcerative colitis (UC). However, there are no head-to-head stud...
12/20/2024
S6
Mental Disorders and Correlated Factors in Patients With Inflammatory Bowel Disease
Background:
12/20/2024
S8
Patients' Beliefs on the Causes of Inflammatory Bowel Disease in the Addressing Disability Effectively With Psychosocial Telemedicine (ADEPT) Trial
Background: Illness perceptions are the cognitive and emotional meanings that patients attach to their disease. A key component of illness perceptions is causal beliefs, which can shape h...
12/20/2024
S6
The Impact of Implementing Clinic-Administered Vaccines in an Inflammatory Bowel Disease Outpatient Clinic
Background:
12/20/2024
S8
LigaSure-Assisted Transanal Division of a Pouch Septum: A Stapler is Not Always the Answer
Background: For medically refractory ulcerative colitis (UC), total proctocolectomy with ileal pouch-anal anastomosis (IPAA) is the surgical intervention of choice. A rare complication of...
12/20/2024
S6
Investigating the Association Between Hidradenitis Suppurativa and Inflammatory Bowel Disease: A Real-World Comparison Study of Crohn’s Disease and Ulcerative Colitis
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition often associated with inflammatory bowel disease (IBD), particularly Crohn’s disease (CD) and...
12/20/2024
S9
Proton Pump Inhibitor Use is Associated with Worse Clinical Outcomes in Patients with Inflammatory Bowel Disease
Background: Proton pump inhibitor (PPI) use is associated with reduced diversity of the gut microbiome and may increase the risk of enteric infections. However, there is limited data on t...
12/20/2024
S7
The Hidden Costs of Inflammatory Bowel Disease Care: A Time and Motion Study of Hospital-Based Biologic Infusions
Background:
12/20/2024
S9
Prevalence of Anxiety and Depression Symptoms in Patients With Ulcerative Colitis in Remission: A Latin American Perspective
Background: Patients with inflammatory bowel disease (IBD) are at risk of developing symptoms of common mental disorders, such as anxiety and depression, due to the bidirectional gut-brai...
12/20/2024
S7
A Multicenter, Prospective, Noninterventional Study of the Real-World Effectiveness of Etrasimod in Patients With Ulcerative Colitis (ENDEAVOUR-UC) Living in the United States
Background:
12/20/2024
S9
Evaluating the Effectiveness of Subcutaneous Ustekinumab Induction in Inflammatory Bowel Disease: Insights From Real-World Evidence
Background:
12/20/2024
S8
Cardiovascular Risk in Patients With Inflammatory Bowel Disease on Janus Kinase Inhibitors Versus Tumor Necrosis Factor Inhibitors: A Real-World Study in a Cardiovascular Risk-Enriched Population
Background:
12/20/2024
S10
Clinical Outcomes of African American Patients With Crohn's Disease: A Population-Based Study
Background: Crohn’s disease is a type of chronic inflammatory bowel disease (IBD), characterized by transmural inflammation of both small and large bowel, leading to persistent...
12/20/2024
S9
Anxiety is Associated With Increased Inflammatory Bowel Disease Disorder Disease Activity: Use of Retrospective Health Assessment Data and Generalized Anxiety Disorder Can Identify High-Risk Populations of Inflammatory Bowel Disease
Background:
12/20/2024
S10
Respiratory Syncytial Virus Vaccination Rates in Patients With Inflammatory Bowel Disease
Background:
12/20/2024
S10
Impact of Obesity on the Outcomes in Patients With Ulcerative Colitis Treated With Advanced Therapies: A Retrospective Cohort Study
Background: Obesity has been associated with a more severe phenotype of Crohn’s disease (CD), and ulcerative colitis (UC), characterized by decreased rates of corticosteroid-fr...
12/20/2024
S10
Outcome of 5-Aminosalicylate (5-ASA) Continuation Versus Discontinuation in Patients With Inflammatory Bowel Disease Started on Biologic Therapy: A Systematic Review and Meta-analysis
Background: Patients with inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), started on biological therapy are usually continued on 5...
12/20/2024
S11
Patients' Preference and Acceptability of Inflammatory Bowel Diseases Self-Help Interventions: CORE Study (Confidence Optimization through Resources for Education, Engagement, and Empowerment)
Background: Patients with chronic diseases often seek health information and self-management tools. It is not known the type of self-help tools that patients with IBD prefer to use, how t...
12/20/2024
S11
External Validation of the Eliakim Score in Capsule Panendoscopy: An Effective Tool for Diagnosis and Monitoring of Crohn's Disease
Background: Capsule panendoscopy is increasingly used in Crohn’s disease (CD), particularly in patients with extensive small bowel and colonic involvement. It offers a non-inva...
12/20/2024
S11
First-Dose Infusion Reaction to Ustekinumab is Associated With the Presence of Serum IgE Against Galactose-α-1,3-Galactose (α-gal)
Background:
12/20/2024
S11
Infliximab Biosimilars in Pediatric Inflammatory Bowel Disease: Comparison and Adverse Effects
Background:
12/20/2024
S12
The Real-Time Nondrug Cost Savings of Switching Patients With Inflammatory Bowel Disease From Intravenous to Subcutaneous Vedolizumab: A Time and Motion Study
Background: Vedolizumab, a standard biologic therapy for ulcerative colitis (UC), is traditionally administered intravenously. While the recent availability of subcutaneous (SC) vedolizum...
12/20/2024
S12
Significant Dissatisfaction and Barriers Exist in the Electronic Health Record Management of Patients With Inflammatory Bowel Disease
Background: Electronic health records (EHRs) were designed to improve the efficiency and quality of patient care. However, EHRs have become a source of significant burden related to the e...
12/20/2024
S12
Mirikizumab Improved the Quality of Life in Patients with Crohn's Disease Regardless of Their Previous Biologic Failure Status: Results from the Phase 3 VIVID-1 Study
Background: The phase 3, active-controlled, VIVID-1 study (NCT03926130) showed the efficacy of mirikizumab, an anti-IL-23p19 antibody, versus placebo (PBO) and ustekinumab in adults with ...
12/20/2024
S13
Influence of Primary Sclerosing Cholangitis on Colorectal Cancer Characteristics in Patients With Inflammatory Bowel Disease: A Retrospective Study
Background: Inflammatory bowel diseases (IBD) and primary sclerosing cholangitis (PSC) are associated with an elevated risk of colorectal cancer (CRC). While ongoing colonic inflammation ...
12/20/2024
S13
Impact of Comprehensive Pharmacy Services on Inflammatory Bowel Disease Patient Care at Ochsner Health
Background: The increasing prevalence of inflammatory bowel disease (IBD) and advancements in treatment options, such as biologics and targeted small molecules, have significantly improve...
12/20/2024
S13
Barriers to Inflammatory Bowel Disease Care in a Majority Hispanic Population: A Patient Survey
Background:
12/20/2024
S14
Endoscopic Response to Subcutaneous Infliximab Across All Segments of the Colon and Terminal Ileum
Background: Endoscopic healing (EH) is associated with positive outcomes in Crohn’s disease (CD). Although patterns of EH vary for different therapeutic agents, most show a low...
12/20/2024
S14
Gender Differences in Mental Health in Patients with Inflammatory Bowel Disease
Background:
12/20/2024
S14
Pouch Septum after Ileoanal Pouch: A Systematic Review of Literature
Background: Rarely, when ileoanal pouches (IPAA) are constructed using a mid-pouch enterotomy to fire the pouch body staple lines, a full-thickness septum of undivided tissue at the pouch...
12/20/2024
S14
Corticosteroid-Free Efficacy and Safety of Ulcerative Colitis Patients Receiving Once-Daily Obefazimod in an Open-Label, 96-Week Maintenance Study Among Patients Who Were Receiving Concomitant Corticosteroids at Induction Baseline
Background: Obefazimod (Obe) is an oral, once-daily (od) small molecule that enhances expression of microRNA-124 and is in phase 3 trials for moderately to severely active ulcerative coli...
12/20/2024
S15
Efficacy of Nirmatrelvir/Ritonavir (Paxlovid) for COVID-19 in Vaccinated Patients With Inflammatory Bowel Disease
Background:
12/20/2024
S15
Association Between Inflammatory Bowel Disease and Hidradenitis Suppurativa: A Single-Center Retrospective Study
Background: Studies have shown an association between inflammatory bowel disease (IBD) and hidradenitis suppurativa (HS), but there is conflicting data on whether it is more associated wi...
12/20/2024
S15
Ironing Out the Efficacy and Safety Profile of Ferric Carboxymaltose Infusions for the Treatment of Iron Deficiency and Iron-Deficiency Anemia in Pediatric Inflammatory Bowel Disease
Background:
12/20/2024
S17
Risk of Venous Thromboembolism After Medical Hospitalization for Inflammatory Bowel Disease
Background:
12/20/2024
S16
Utility of Red Cell Distribution Width in Assessing Ulcerative Colitis Activity and Its Correlation With Inflammatory Biomarkers
Background:
12/20/2024
S17
Prevalence of QuantiFERON Positivity in Patients With Inflammatory Bowel Disease Eligible for Biological Therapy: Clinical and Demographic Analysis
Background:
12/20/2024
S16
Ultrasound Assessment of the Muscles for Sarcopenia Diagnosis in Patients With Inflammatory Bowel Disease
Background: Sarcopenia is a progressive pathological condition which can present in inflammatory bowel disease (IBD) together with changes in body composition. Aim. To provide ultrasound ...
12/20/2024
S17
Clinical Outcomes for Crohn’s Disease Patients With Thrombocytopenia: A Retrospective Cohort Study
Background: Crohn’s disease is a type of chronic inflammatory bowel disease (IBD), characterized by transmural inflammation of both small and large bowel, leading to persistent...
12/20/2024
S16
Herpes Simplex Virus Colitis After Treatment With Upadacitinib
Background: JAK inhibitors are known to increase the risk of herpes virus infections, most commonly herpes zoster. Although less frequently reported, reactivation of herpes simplex virus ...
12/20/2024
S18
Advancement in Care: Implementation of the Inflammatory Bowel Disease Navigation Program in Brazil
Background: The inflammatory bowel disease (IBD) navigation program represents a significant advancement in the approach to these complex conditions. This study aims to report on the impl...
12/20/2024
S16
Advances in Adalimumab Biosimilar Usage in a Statewide Health System
Background:
12/20/2024
S19
The Patient's Journey Through Inflammatory Bowel Disease: Diagnostic Delay and Its Clinical and Socioeconomic Impact
Background:
12/20/2024
S17
Assessing Attitudes, Access, Barriers, and Facilitators to Multidisciplinary Care in Pediatric Inflammatory Bowel Disease
Background:
12/20/2024
S20
Subgroup Analysis of Ozanimod Efficacy by Prior Biologic Exposure in Japanese Patients With Ulcerative Colitis from the Phase 2/3 J-True North Study
Background: Ozanimod, a selective sphingosine 1-phosphate receptor modulator, is approved for the treatment of moderately to severely active ulcerative colitis (UC) in the United States a...
12/20/2024
S18
Caught Between a Cough and a Hard Place: A Crohn's Conundrum with a Broncho-Esophageal Twist
Background:
12/20/2024
S20
Rechallenge With Subcutaneous Mirikizumab After Mild Hypersensitivity Reaction to Intravenous Mirikizumab in a Patient With Ulcerative Colitis and Primary Sclerosing Cholangitis
Background:
12/20/2024
S18
Mail-Order Stool Testing Improves Patient Experience in Patients With Inflammatory Bowel Disease
Background:
12/20/2024
S21
Proactive Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease Patients Receiving Infliximab and Biosimilars
Background: Inflammatory bowel disease (IBD) in children has become more prevalent in the past decade. Infliximab and its biosimilars use in pediatric IBD have increased. Therapeutic drug...
12/20/2024
S18
Increase in Prevalence of Inflammatory Bowel Disease Among Insured Patients in Puerto Rico from 2018 to 2022
Background: The prevalence of inflammatory bowel disease (IBD) is higher in Western Europe compared to other regions, and rates are increasing in racial and ethnic minorities and in count...
12/20/2024
S21
C-reactive Protein/Albumin Ratio as a Marker to Predict Clinical and Endoscopic Response to Medical Treatment in Mexican Outpatients With Ulcerative Colitis
Background:
12/20/2024
S19
Linear IgA Bullous Dermatosis and Agranulocytosis in a Patient With Crohn's Disease
Background: A variety of dermatological lesions can be associated with inflammatory bowel diseases (IBD). Linear IgA bullous dermatosis (LABD) is a rare autoimmune condition that may be d...
12/20/2024
S22
Strategies for the Treatment of Dysplasia at an Institution in Japan
Background:
12/20/2024
S19
Impact of Precision-Guided Dosing on Clinical Decision Making and Health Care Utilization in Inflammatory Bowel Disease: A 24-Month Real-World Outcome Comparison Before and After Test Implementation
Background: Precision-guided dosing (PGD) is a personalized medicine tool to guide informed clinical decision making for the treatment of inflammatory bowel disease (IBD) with infliximab ...
12/20/2024
S23
Group Medical Care: A New Model of Care in Inflammatory Bowel Disease: Does the Patient Feel Satisfied?
Background:
12/20/2024
S20
Atypical Abdominal Pain: Uncovering Malignant Peritoneal Mesothelioma in Suspected Crohn's Disease: A Case Report
Background: Malignant peritoneal mesothelioma (MPM) is a rare malignancy confined to the abdominal cavity. Most cases occur in Whites. Industrial pollutants including asbestos exposure is...
12/20/2024
S23
Clinical Impact of Vedolizumab Treatment in Patients With Ulcerative Colitis: Evidence from a Real-World Study in Mexico
Background:
12/20/2024
S20
Exploring Twisted Pouch Syndrome in Ileal Pouch-Anal Anastomosis: A Scoping Review on Diagnosis, Treatment, and Prevention
Background: Twisted pouch syndrome (TPS) is a rare complication in patients undergoing ileal pouch-anal anastomosis (IPAA) for ulcerative colitis (UC) and familial adenomatous polyposis (...
12/20/2024
S24
Teprotumumab-Induced Ulcerative Colitis: A Case Report and Review of the Literature
Background: Teprotumumab, an IGF-1 receptor antagonist, is primarily used for the treatment of thyroid eye disease. While its efficacy in reducing the severity of this condition is well-d...
12/20/2024
S21
Rapid Versus Standard Infliximab and Infliximab Biosimilar Infusions in Pediatric Inflammatory Bowel Disease: Comparison of Adverse Reactions
Background:
12/20/2024
S24
Effectiveness and Safety of Tofacitinib in the Management of Ulcerative Colitis: A Brazilian Observational Multicentric Study
Background: Tofacitinib is an oral pan-JAK inhibitor approved for treatment of several immune-mediated inflammatory disorders, including ulcerative colitis (UC). We aimed to assess the re...
12/20/2024
S22
Symptomatic Bradycardia: A Rarely Reported Manifestation of Crohn's Disease Flare-up and Mesalamine Use
Background:
12/20/2024
S24
Virtual Endoscopy Can Detect More Dysplasia in Patients With Inflammatory Bowel Disease
Background: Epithelial dysplasia is a risk for colon cancer in patients with long-standing inflammatory bowel disease. The rates of dysplasia detection using virtual-based versus dye-base...
12/20/2024
S22
Severe Fistulizing Crohn's-Like Disease in a Patient With Common Variable Immunodefficiency
Background:
12/20/2024
S25
Association Between Small Bowel Lesion Activity and Fecal Calprotectin in Pediatric Crohn's Disease
Background:
12/20/2024
S22
CAR T-Cell Therapy Associated With Onset of Inflammatory Bowel Disease Requiring Long-Term Advanced Therapy for Control of Chronic Ileocolitis
Background: Chimeric antigen receptor (CAR) T-cell therapy is a novel treatment for a broad spectrum of malignant conditions however complications are still being defined. Case reports ha...
12/20/2024
S25
Successful Use of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Short Gut Syndrome in Patients With Inflammatory Bowel Disease
Background:
12/20/2024
S23
Refractory Lymphocytic Colitis Treated With Upadacitinib
Background:
12/20/2024
S25
Measurement of Clinical Documentation Burden Associated With Tracking Immunology-Related Products Requiring Intravenous Induction and Subcutaneous Maintenance
Background:
12/20/2024
S23
Recurrent Hemorrhagic Enteritis: A Challenging Case of Presumed Proximal Small Bowel Crohn's Disease
Background: Isolated upper gastrointestinal (GI) Crohn’s disease can present a significant diagnostic challenge. It is relatively uncommon and has protean clinical manifestatio...
12/20/2024
S26
Impact of Obesity on the Course of Inflammatory Bowel Disease
Background:
12/20/2024
S24
Addressing Medical Trauma in Young Adults With Inflammatory Bowel Disease: A Roadmap for Patient-Centered Resources and Collaborative Care
Background:
12/20/2024
S26
Ileoanal Pouch Surgery Online Patient Resources: An Assessment of Quality and Readability
Background: The purpose was to assess the quality and readability of online information regarding J-pouch surgery across academic, commercial, and foundation/advocacy websites. Methods: ...
12/20/2024
S25
A Quality Improvement Project to Improve Hepatitis B Vaccination Among Immunocompromised Patients With Inflammatory Bowel Disease
Background:
12/20/2024
S27
Efficacy of Combined Therapy With 5-Aminosalicylic Acids in Patients With Ulcerative Colitis With Isolated Biochemical Activity: A Real-Life Study
Background:
12/20/2024
S26
Artificial Intelligence in Inflammatory Bowel Disease: A Pilot Study on ChatGPT and Copilot's Impact on Health Literacy in Ulcerative Colitis and Crohn's Disease
Background:
12/20/2024
S27
Clinical Outcomes for Crohn's Disease Patients With Hyperlipidemia: An Analysis of the National Inpatient Sample
Background: Crohn’s disease is a type of chronic inflammatory bowel disease (IBD), characterized by transmural inflammation of both small and large bowel, leading to persistent...
12/20/2024
S26
Dose Modification of Induction Risankizumab in a Liver Transplant J-Pouch Patient With de Novo Crohn's Disease
Background: Risankizumab, a monoclonal antibody that targets the p19 subunit of interleukin-23, is approved for both moderate to severe Crohn’s disease (CD) and ulcerative coli...
12/20/2024
S27
Frequency and Analysis of Deep Remission in Patients With Ulcerative Colitis: A Single-Center Retrospective Study
Background:
12/20/2024
S28
Ethnic Variations and Their Consequences: Ulcerative Colitis After Bariatric Procedures
Background: Bariatric surgery effectively treats obesity and boosts metabolic health, but it may increase ulcerative colitis (UC) incidence, particularly after the Roux-en-Y gastric bypas...
12/20/2024
S28
Single-Center Experience With Upadacitinib 45-mg Reinduction for Ulcerative Colitis
Background:
12/20/2024
S28
New-Onset Ulcerative Colitis Associated to Ixekizumab
Background:
12/20/2024
S28
Anxiety Screening in Pediatric Patients With Inflammatory Bowel Disease
Background:
12/20/2024
S28
Detection Rate of Colorectal Dysplasia in Inflammatory Bowel Diseases
Background: The improvement in the quality of endoscopic equipment that aids in the diagnosis in cases of suspected dysplasia, associated with the expertise of endoscopists in inflammator...
12/20/2024
S29
Clinical Outcomes of Obese Patients With Crohn's Disease: A Retrospective Cohort Study
Background: Crohn’s disease is a type of chronic inflammatory bowel disease (IBD), characterized by transmural inflammation of both small and large bowel, leading to persistent...
12/20/2024
S29
Itching for Therapy: Alpha-Gal Syndrome as a Cause of Anaphylaxis to Ustekinumab
Background:
12/20/2024
S31
Extraintestinal Manifestations in Inflammatory Bowel Disease: The Experience at Cleveland Clinic Abu Dhabi, A Large Tertiary Hospital in United Arab Emirates
Background:
12/20/2024
S29
Not All that Perforates is Ulcerative Colitis: A Case of Severe Fulminant Cytomegalovirus Colitis Leading to Total Colectomy With End Ileostomy in New Diagnosis of Inflammatory Bowel Disease
Background: Cytomegalovirus (CMV) can cause severe multi organ infections in immunocompromised individuals. CMV colitis often presents with nonspecific symptoms such as diarrhea, abdomina...
12/20/2024
S31
Treatment of Concomitant Alopecia Areata and Crohn's Disease in a Young Child With Tofacitinib: Case Report
Background:
12/20/2024
S29
Novel Use of a Biologic Agent for an Uncommon Complication of an Old Surgery: Successful Use of Ustekinumab for Kock Pouchitis
Background:
12/20/2024
S31
Thyroid Cancer in Inflammatory Bowel Disease
Background: The incidence of malignancy is increased in patients with inflammatory bowel disease (IBD), with increased incidence of colorectal cancer in patients with ulcerative colitis (...
12/20/2024
S30
Risk of Serious and Opportunistic Infections Associated With Advanced Therapy in Inflammatory Bowel Disease Patients from an Academic Center in Brazil
Background: The risks of serious and opportunistic infection associated with the various targeted therapies for inflammatory bowel disease (IBD) is one of the main concerns of clinicians ...
12/20/2024
S31
Analysis of Fistula Cases in Crohn's Disease Patients from Brazilian National GEDIIB Registry
Background: Inflammatory bowel diseases (IBD) manifest in various forms, significantly impacting patients’ quality of life. Crohn’s disease (CD) can lead to the deve...
12/20/2024
S30
Total Telemedicine Pathway for Inflammatory Bowel Disease Surgical Care Expands Access to an Academic Inflammatory Bowel Disease Center
Background:
12/20/2024
S32
Diagnostic Transition from Ulcerative Colitis to Crohn's Disease: A Single-Center Retrospective Study
Background:
12/20/2024
S30
Effect of Plasmapheresis on Ustekinumab Levels
Background: Plasmapheresis is a way to remove toxic substances from the body. However, it can also result in removal of necessary substances such as medications. Here we present a patient...
12/20/2024
S32
Lack of Health Equity in Rural Missouri's Bollinger County Led to Delayed Diagnosis and Higher Adverse Outcomes for Inflammatory Bowel Disease Patients and Reduced Colorectal Cancer Screening Rates
Background:
12/20/2024
S32
Crohn's Disease and Small Bowel Adenocarcinoma: An Unexpected Finding
Background: Small bowel adenocarcinomas (SBA) are rare, comprising about 1-3% of all malignant GI tumors. Evidence suggests that patients with Crohn’s disease (CD) are at incre...
12/20/2024
S32
Prevalence and Predictors of Fatigue in Patients With Inflammatory Bowel Disease in Saudi Arabia
Background: Inflammatory bowel disease (IBD) is a growing health concern in the Western region of Saudi Arabia, and fatigue is an often overlooked symptom with scarcity of research on its...
12/20/2024
S33
Pharmacological Efficacy and Treatment Satisfaction in Patients With Inflammatory Bowel Diseases in a Tertiary Care Setting
Background: Patients with inflammatory bowel diseases (IBDs) require a precise pharmacological regimen to manage their condition effectively. The complexity in therapeutic approach arises...
12/20/2024
S33
Frequency and Characteristics of Anorectal Pathologies in Patients With Inflammatory Bowel Disease
Background:
12/20/2024
S12
Curcumin-QingDai Combination for Patients With Active Crohn's Disease: Initial Real-World Experience from a Retrospective Multicenter Cohort Study
Background: A combination of curcumin and QingDai (CurQD) was shown to be effective in ulcerative colitis but its benefit in Crohn’s disease (CD) has not been studied. Methods:...
12/20/2024
S13
Assessing the Impact of Medication-Induced Adrenal Insufficiency and Access to Care on Inpatient Clinical Outcomes in Patients With Inflammatory Bowel Disease: An Analysis of the National Inpatient Sample, 2016-2020
Background:
12/20/2024
S21
Feasibility and Safety of Endoscopic Submucosal Dissection for Ulcerative Colitis-Associated Neoplasia
Background: Patients with ulcerative colitis (UC) are at an increased risk of UC-associated neoplasia (UCAN). Endoscopic submucosal dissection (ESD) is an acceptable treatment option for ...
12/20/2024
S27
Demographic Analysis of Patients With Ulcerative Colitis Undergoing Restorative Proctocolectomy With Ileal Pouch-Anal Anastomosis: A Single-Center Study Over the Past 12 Years
Background:
12/20/2024

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use